Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Developing a physiologically based approach for modeling plutonium decorporation therapy with DTPA.

Manuel Kastl1, Augusto Giussani, Eric Blanchardon

  • 1Helmholtz Zentrum München, Research Unit Medical Radiation Physics and Diagnostics , Neuherberg , Germany.

International Journal of Radiation Biology
|May 22, 2014
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of CT dose-averaged detectability: a repeatability study.

Zeitschrift fur medizinische Physik·2026
Same author

Biokinetic modelling of the exhalation of <sup>219</sup>Rn gas and its airborne progeny from patients undergoing treatment with <sup>223</sup>Ra-dichloride and effective dose estimation for caregivers.

Radiation and environmental biophysics·2026
Same author

Reconstruction of the radiological component of the exposome in the CONSTANCES cohort.

The Science of the total environment·2026
Same author

Reference Levels for Diagnostic and Interventional X-ray Exposures in Germany: Development, Handling, and Perspective.

RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin·2026
Same author

Effective dose and risk assessment in 18F-FDG PET/CT examinations of lymphoma patients using updated dose coefficients.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2026
Same author

Dose coefficients to the fetus and offspring from intakes of radionuclides by the mother.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2025

This study models plutonium decorporation therapy using Diethylenetriaminepentaacetic acid (DTPA). The enhanced model accounts for plutonium speciation in blood, improving understanding of decorporation mechanisms.

Area of Science:

  • Radiochemistry
  • Pharmacokinetics
  • Biomedical Modeling

Background:

  • Plutonium (Pu) decorporation therapy aims to remove internally deposited plutonium from the body.
  • Diethylenetriaminepentaacetic acid (DTPA) is a chelating agent used for decorporation therapy.
  • Accurate modeling of plutonium biokinetics and decorporation is crucial for effective treatment.

Purpose of the Study:

  • To develop a physiologically based compartmental model for plutonium decorporation therapy.
  • To incorporate the chelating agent Diethylenetriaminepentaacetic acid (DTPA) into the model.
  • To refine existing biokinetic models for plutonium.

Main Methods:

  • Utilized the SAAM II software package for model calculations.
  • Employed the Luciani/Polig compartmental model for plutonium biokinetics, including age-dependent bone recycling.
Keywords:
Biokinetic modelingDTPAactinideschelationdecorporationplutonium

Related Experiment Videos

  • Modified the model to account for plutonium speciation in blood and DTPA affinity.

    • Main Results:

    • Introduced separate blood compartments for low-molecular-weight plutonium complexes (Pu-LW) and transferrin-bound plutonium (Pu-Tf).
    • Added a compartment for plutonium in interstitial fluids.
    • Successfully integrated these compartments into the existing biokinetic model.

    Conclusions:

    • The developed model provides a more detailed representation of plutonium distribution in the body.
    • Future work will focus on modeling the chelation process with DTPA.
    • Animal studies are planned to validate the model and elucidate decorporation mechanisms.